Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A researcher's view.

H S Horowitz1

  • 1Dental Research and Public Health, Bethesda, MD 20817.

Journal of Public Health Dentistry
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

The Food and Drug Administration (FDA) needs to update its dental drug regulations to reflect new scientific findings. The American Dental Association (ADA) effectively ensures dental product safety and efficacy through its voluntary programs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decision-making for national programs of community fluoride use.

Community dentistry and oral epidemiology·2000
Same author

Why I continue to support community water fluoridation.

Journal of public health dentistry·2000
Same author

The role of dietary fluoride supplements in caries prevention.

Journal of public health dentistry·2000
Same author

Proper use of fluoride products in fluoridated communities.

Lancet (London, England)·1999
Same author

Fluoride--an element in good company.

Journal of public health dentistry·1999
Same author

Research issues in early childhood caries.

Community dentistry and oral epidemiology·1998
Same journal

Synergistic Effects of Social Determinants of Health and Periodontitis on Premature Cardiovascular Mortality: A Nationally Representative Cohort Study.

Journal of public health dentistry·2026
Same journal

Incarceration History, Dental Care Utilization, and Oral Health Difficulties Among U.S. Military Veterans.

Journal of public health dentistry·2026
Same journal

Can Artificial Intelligence Substitute Dental Public Health Expertise? A Competency-Based Analysis Across Core DPH Domains.

Journal of public health dentistry·2026
Same journal

From Evidence to Engagement: Understanding Online Resistance to Community Water Fluoridation for Public Health Communication-A Qualitative Study.

Journal of public health dentistry·2026
Same journal

Custodial Dental Care in Federal Courts: A Systematic Review of Appellate Decisions and Implications for Public Health.

Journal of public health dentistry·2026
Same journal

From Policy Endorsement to Programmatic Delivery: The Persistent Implementation Gap of Silver Diamine Fluoride in the Global South.

Journal of public health dentistry·2026
See all related articles

Area of Science:

  • Regulatory Science
  • Dental Public Health
  • Pharmaceutical Regulation

Background:

  • The Food and Drug Administration (FDA) plays a crucial role in ensuring the safety and efficacy of healthcare products.
  • The regulation of dental drug products by the FDA has been perceived as inflexible and slow to incorporate new scientific information.

Purpose of the Study:

  • To evaluate the FDA's regulatory approach to dental drug products in light of current scientific advancements.
  • To compare the FDA's regulatory function with the American Dental Association's (ADA) product acceptance programs.

Main Methods:

  • Qualitative assessment of the FDA's regulatory stance on dental therapeutics.
  • Review of the ADA's Council on Dental Therapeutics' processes for product evaluation and acceptance.

Related Experiment Videos

  • Comparative analysis of regulatory effectiveness and responsiveness to scientific research.

    • Main Results:

    • The FDA's regulatory framework for dental drugs has not adequately adapted to new scientific evidence, attributed to agency size, insufficient dental expertise, and outdated research engagement.
    • The ADA's voluntary acceptance and certification programs demonstrate a consistent ability to stay current with dental research and public health issues.
    • The ADA's Council on Dental Therapeutics effectively utilizes expert consultation to ensure product safety and efficacy.

    Conclusions:

    • The FDA faces challenges in intelligently regulating dental drug products due to internal limitations.
    • The ADA's proactive and expert-driven approach provides a robust model for ensuring the safety and effectiveness of dental products.
    • Both regulatory bodies contribute to protecting public oral health, but the FDA requires modernization.